Copyright © 2008 Joëlle Dupont et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. W. R. Butler, “Nutritional interactions with reproductive performance in dairy cattle,” Animal Reproduction Science, vol. 60-61, pp. 449–457, 2000. View at Publisher · View at Google Scholar
2. R. Fernandez-Fernandez, A. C. Martini, and V. M. Navarro, et al., “Novel signals for the integration of energy balance and reproduction,” Molecular and Cellular Endocrinology, vol. 254-255, pp. 127–132, 2006. View at Publisher · View at Google Scholar · View at PubMed
3. D. J. Burks, J. F. de Mora, and M. Schubert, et al., “IRS-2 pathways integrate female reproduction and energy homeostasis,” Nature, vol. 407, no. 6802, pp. 377–382, 2000. View at Publisher · View at Google Scholar · View at PubMed
4. J. C. Bruning, D. Gautam, and D. J. Burks, et al., “Role of brain insulin receptor in control of body weight and reproduction,” Science, vol. 289, no. 5487, pp. 2122–2125, 2000. View at Publisher · View at Google Scholar
5. A. Dunaif, “Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis,” Endocrine Reviews, vol. 18, no. 6, pp. 774–800, 1997. View at Publisher · View at Google Scholar
6. M. J. Iuorno and J. E. Nestler, “Insulin-lowering drugs in polycystic ovary syndrome,” Obstetrics and Gynecology Clinics of North America, vol. 28, no. 1, pp. 153–164, 2001. View at Publisher · View at Google Scholar
7. E. Seli and A. J. Duleba, “Treatment of PCOS with metformin and other insulin-sensitizing agents,” Current Diabetes Reports, vol. 4, no. 1, pp. 69–75, 2004. View at Publisher · View at Google Scholar
8. J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer, “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor $\gamma$ (PPAR$\gamma$),” Journal of Biological Chemistry, vol. 270, no. 22, pp. 12953–12956, 1995. View at Publisher · View at Google Scholar
9. N. Musi, M. F. Hirshman, and J. Nygren, et al., “Metformin increases AMP-activated protein-kinase activity in skeletal muscle of subjects with type 2 diabetes,” Diabetes, vol. 51, no. 7, pp. 2074–2081, 2002. View at Publisher · View at Google Scholar
10. M. S. Ardawi and A. A. Rouzi, “Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 83, no. 6, pp. 1708–1716, 2005. View at Publisher · View at Google Scholar · View at PubMed
11. T. Kadowaki and T. Yamauchi, “Adiponectin and adiponectin receptors,” Endocrine Reviews, vol. 26, no. 3, pp. 439–451, 2005. View at Publisher · View at Google Scholar · View at PubMed
12. C. Chabrolle, L. Tosca, and J. Dupont, “Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis,” Reproduction, vol. 133, no. 4, pp. 719–731, 2007. View at Publisher · View at Google Scholar · View at PubMed
13. C. Chabrolle, L. Tosca, S. Crochet, S. Tesseraud, and J. Dupont, “Expression of adiponectin and its receptors (AdipoR1 and AdipoR2) in chicken ovary: potential role in ovarian steroidogenesis,” to appear in Domestic Animal Endocrinology. View at Publisher · View at Google Scholar · View at PubMed
14. R. Mattos, C. R. Staples, and W. W. Thatcher, “Effects of dietary fatty acids on reproduction in ruminants,” Reviews of Reproduction, vol. 5, no. 1, pp. 38–45, 2000. View at Publisher · View at Google Scholar
15. C. M. Garcia-Bojalil, C. R. Staples, C. A. Risco, J. D. Savio, and W. W. Thatcher, “Protein degradability and calcium salts of long-chain fatty acids in the diets of lactating dairy cows: reproductive responses,” Journal of Dairy Science, vol. 81, no. 5, pp. 1385–1395, 1998.
16. B. P. Kota, T. H.-W. Huang, and B. D. Roufogalis, “An overview on biological mechanisms of PPARs,” Pharmacological Research, vol. 51, no. 2, pp. 85–94, 2005. View at Publisher · View at Google Scholar · View at PubMed
17. D. G. Hardie and D. Carling, “The AMP-activated protein kinase—fuel gauge of the mammalian cell?,” European Journal of Biochemistry, vol. 246, no. 2, pp. 259–273, 1997. View at Publisher · View at Google Scholar
18. S. Han and J. Roman, “Rosiglitazone suppresses human lung carcinoma cell growth through PPAR$\gamma$-dependent and PPAR$\gamma$-independent signal pathways,” Molecular Cancer Therapeutics, vol. 5, no. 2, pp. 430–437, 2006. View at Publisher · View at Google Scholar · View at PubMed
19. N. K. LeBrasseur, M. Kelly, and T.-S. Tsao, et al., “Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues,” American Journal of Physiology, vol. 291, no. 1, pp. E175–E181, 2006. View at Publisher · View at Google Scholar · View at PubMed
20. L. G. Fryer, A. Parbu-Patel, and D. Carling, “The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways,” Journal of Biological Chemistry, vol. 277, no. 28, pp. 25226–25232, 2002. View at Publisher · View at Google Scholar · View at PubMed
21. G. Pilon, P. Dallaire, and A. Marette, “Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs,” Journal of Biological Chemistry, vol. 279, no. 20, pp. 20767–20774, 2004. View at Publisher · View at Google Scholar · View at PubMed
22. M. R. Owen, E. Doran, and A. P. Halestrap, “Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain,” Biochemical Journal, vol. 348, no. 3, pp. 607–614, 2000. View at Publisher · View at Google Scholar
23. C. M. Komar, “Peroxisome proliferator-activated receptors (PPARs) and ovarian function—implications for regulating steroidogenesis, differentiation, and tissue remodeling,” Reproductive Biology and Endocrinology, vol. 3, pp. 31, 2005. View at Publisher · View at Google Scholar · View at PubMed
24. K. S. Miyata, S. E. McCaw, S. L. Marcus, R. A. Rachubinski, and J. P. Capone, “The peroxisome proliferator-activated receptor interacts with the retinoid X receptor in vivo,” Gene, vol. 148, no. 2, pp. 327–330, 1994. View at Publisher · View at Google Scholar
25. B. Desvergne and W. Wahli, “Peroxisome proliferator-activated receptors: nuclear control of metabolism,” Endocrine Reviews, vol. 20, no. 5, pp. 649–688, 1999. View at Publisher · View at Google Scholar
26. F. Picard and J. Auwerx, “PPAR$\gamma$ and glucose homeostasis,” Annual Review of Nutrition, vol. 22, pp. 167–197, 2002. View at Publisher · View at Google Scholar · View at PubMed
27. Y. Kobayashi, S. Ueki, and G. Mahemuti, et al., “Physiological levels of 15-deoxy-${\Delta }^{12,14}$-prostaglandin ${\text{J}}_2$ prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-$\gamma$ ligation,” Journal of Immunology, vol. 175, no. 9, pp. 5744–5750, 2005.
28. T. Leff, “AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins,” Biochemical Society Transactions, vol. 31, part 1, pp. 224–227, 2003.
29. O. Braissant, F. Foufelle, C. Scotto, M. Dauça, and W. Wahli, “Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-$\alpha$, -$\beta$, and -$\gamma$ in the adult rat,” Endocrinology, vol. 137, no. 1, pp. 354–366, 1996. View at Publisher · View at Google Scholar
30. G. Krey, O. Braissant, and F. L'Horset, et al., “Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay,” Molecular Endocrinology, vol. 11, no. 6, pp. 779–791, 1997. View at Publisher · View at Google Scholar
31. K. Schoonjans, B. Staels, and J. Auwerx, “Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression,” Journal of Lipid Research, vol. 37, no. 5, pp. 907–925, 1996.
32. Y.-C. Zhou and D. J. Waxman, “Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids,” Environmental Health Perspectives, vol. 106, supplement 4, pp. 983–988, 1998. View at Publisher · View at Google Scholar
33. A. Shalev, C. A. Siegrist-Kaiser, and P. M. Yen, et al., “The peroxisome proliferator-activated receptor $\alpha$ is a phosphoprotein: regulation by insulin,” Endocrinology, vol. 137, no. 10, pp. 4499–4502, 1996. View at Publisher · View at Google Scholar
34. C. Fiévet, J.-C. Fruchart, and B. Staels, “PPAR$\alpha$ and PPAR$\gamma$ dual agonists for the treatment of type 2 diabetes and the metabolic syndrome,” Current Opinion in Pharmacology, vol. 6, no. 6, pp. 606–614, 2006. View at Publisher · View at Google Scholar · View at PubMed
35. D. G. Hardie, “The AMP-activated protein kinase pathway—new players upstream and downstream,” Journal of Cell Science, vol. 117, no. 23, pp. 5479–5487, 2004. View at Publisher · View at Google Scholar · View at PubMed
36. T. Hayashi, M. F. Hirshman, E. J. Kurth, W. W. Winder, and L. J. Goodyear, “Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport,” Diabetes, vol. 47, no. 8, pp. 1369–1373, 1998. View at Publisher · View at Google Scholar
37. J. Mu, J. T. Brozinick Jr., O. Valladares, M. Bucan, and M. J. Birnbaum, “A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle,” Molecular Cell, vol. 7, no. 5, pp. 1085–1094, 2001. View at Publisher · View at Google Scholar
38. T. Yamauchi, J. Kamon, and Y. Minokoshi, et al., “Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase,” Nature Medicine, vol. 8, no. 11, pp. 1288–1295, 2002. View at Publisher · View at Google Scholar · View at PubMed
39. Y. Minokoshi, Y.-B. Kim, and O. D. Peroni, et al., “Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase,” Nature, vol. 415, no. 6869, pp. 339–343, 2002. View at Publisher · View at Google Scholar · View at PubMed
40. J. M. Corton, J. G. Gillespie, S. A. Hawley, and D. G. Hardie, “5-aminoimidazole-4-carboxamide ribonucleoside—a specific method for activating AMP-activated protein kinase in intact cells?,” European Journal of Biochemistry, vol. 229, no. 2, pp. 558–565, 1995. View at Publisher · View at Google Scholar
41. B. B. Kahn, T. Alquier, D. Carling, and D. G. Hardie, “AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism,” Cell Metabolism, vol. 1, no. 1, pp. 15–25, 2005. View at Publisher · View at Google Scholar · View at PubMed
42. D. G. Hardie, “New roles for the LKB1$\to$AMPK pathway,” Current Opinion in Cell Biology, vol. 17, no. 2, pp. 167–173, 2005. View at Publisher · View at Google Scholar · View at PubMed
43. T. Yamauchi, Y. Nio, and T. Maki, et al., “Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions,” Nature Medicine, vol. 13, no. 3, pp. 332–339, 2007. View at Publisher · View at Google Scholar · View at PubMed
44. P. E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish, “A novel serum protein similar to C1q, produced exclusively in adipocytes,” Journal of Biological Chemistry, vol. 270, no. 45, pp. 26746–26749, 1995. View at Publisher · View at Google Scholar
45. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara, “cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1,” Biochemical and Biophysical Research Communications, vol. 221, no. 2, pp. 286–289, 1996. View at Publisher · View at Google Scholar · View at PubMed
46. U. B. Pajvani and P. E. Scherer, “Adiponectin: systemic contributor to insulin sensitivity,” Current Diabetes Reports, vol. 3, no. 3, pp. 207–213, 2003. View at Publisher · View at Google Scholar
47. T. Yamauchi, J. Kamon, and Y. Minokoshi, et al., “Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase,” Nature Medicine, vol. 8, no. 11, pp. 1288–1295, 2002. View at Publisher · View at Google Scholar · View at PubMed
48. M. Iwaki, M. Matsuda, and N. Maeda, et al., “Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors,” Diabetes, vol. 52, no. 7, pp. 1655–1663, 2003. View at Publisher · View at Google Scholar
49. N. Maeda, M. Takahashi, and T. Funahashi, et al., “$\text{PPAR}\gamma$ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein,” Diabetes, vol. 50, no. 9, pp. 2094–2099, 2001. View at Publisher · View at Google Scholar
50. A. R. Nawrocki, M. W. Rajala, and E. Tomas, et al., “Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor $\gamma$ agonists,” Journal of Biological Chemistry, vol. 281, no. 5, pp. 2654–2660, 2006. View at Publisher · View at Google Scholar · View at PubMed
51. S. Ledoux, D. B. Campos, F. L. Lopes, M. Dobias-Goff, M.-F. Palin, and B. D. Murphy, “Adiponectin induces periovulatory changes in ovarian follicular cells,” Endocrinology, vol. 147, no. 11, pp. 5178–5186, 2006. View at Publisher · View at Google Scholar · View at PubMed
52. C. M. Komar, O. Braissant, W. Wahli, and T. E. Curry Jr., “Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period,” Endocrinology, vol. 142, no. 11, pp. 4831–4838, 2001. View at Publisher · View at Google Scholar
53. S. S. Lee, T. Pineau, and J. Drago, et al., “Targeted disruption of the $\alpha$ isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators,” Molecular and Cellular Biology, vol. 15, no. 6, pp. 3012–3022, 1995.
54. Y. Barak, D. Liao, and W. He, et al., “Effects of peroxisome proliferator-activated receptor $\delta$ on placentation, adiposity, and colorectal cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 303–308, 2002. View at Publisher · View at Google Scholar · View at PubMed
55. J. M. Peters, S. S. Lee, and W. Li, et al., “Growths, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor $\beta \left(\delta \right)$,” Molecular and Cellular Biology, vol. 20, no. 14, pp. 5119–5128, 2000. View at Publisher · View at Google Scholar
56. S. Gasic, Y. Bodenburg, M. Nagamani, A. Green, and R. J. Urban, “Troglitazone inhibits progesterone production in porcine granulosa cells,” Endocrinology, vol. 139, no. 12, pp. 4962–4966, 1998. View at Publisher · View at Google Scholar
57. P. Froment, S. Fabre, and J. Dupont, et al., “Expression and functional role of peroxisome proliferator-activated receptor-$\gamma$ in ovarian folliculogenesis in the sheep,” Biology of Reproduction, vol. 69, no. 5, pp. 1665–1674, 2003. View at Publisher · View at Google Scholar · View at PubMed
58. C. Komar, “Initiation of peroxysome proliferator-activated receptor gamma (PPARg) expression in the neonatal rat ovary,” in Proceedings of the 38th Annual Meeting of the Society for the Study of Reproduction, Quebec City, Quebec, Canada, July 2005.
59. Y. Cui, K. Miyoshi, and E. Claudio, et al., “Loss of the peroxisome proliferation-activated receptor gamma $\left(\text{PPAR}\gamma \right)$ does not affect mammary development and propensity for tumor formation but leads to reduced fertility,” Journal of Biological Chemistry, vol. 277, no. 20, pp. 17830–17835, 2002. View at Publisher · View at Google Scholar · View at PubMed
60. L. Tosca, P. Froment, P. Solnais, P. Ferré, F. Foufelle, and J. Dupont, “Adenosine $5^{\prime }$-monophosphate-activated protein kinase regulates progesterone secretion in rat granulosa cells,” Endocrinology, vol. 146, no. 10, pp. 4500–4513, 2005. View at Publisher · View at Google Scholar · View at PubMed
61. L. Tosca, P. Solnais, P. Ferré, F. Foufelle, and J. Dupont, “Metformin-induced stimulation of adenosine $5^{\prime }$monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells,” Biology of Reproduction, vol. 75, no. 3, pp. 342–351, 2006. View at Publisher · View at Google Scholar · View at PubMed
62. S. M. Downs, E. R. Hudson, and D. G. Hardie, “A potential role for AMP-activated protein kinase in meiotic induction in mouse oocytes,” Developmental Biology, vol. 245, no. 1, pp. 200–212, 2002. View at Publisher · View at Google Scholar · View at PubMed
63. L. Tosca, C. Chabrolle, S. Uzbekova, and J. Dupont, “Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine $5^{\prime }$monophosphate-activated protein kinase (AMPK),” Biology of Reproduction, vol. 76, no. 3, pp. 368–378, 2007. View at Publisher · View at Google Scholar · View at PubMed
64. M. A. Mayes, M. F. Laforest, C. Guillemette, R. B. Gilchrist, and F. J. Richard, “Adenosine $5^{\prime }$-monophosphate kinase-activated protein kinase (PRKA) activators delay meiotic resumption in porcine oocytes,” Biology of Reproduction, vol. 76, no. 4, pp. 589–597, 2007. View at Publisher · View at Google Scholar · View at PubMed
65. L. Tosca, S. Crochet, P. Ferré, F. Foufelle, S. Tesseraud, and J. Dupont, “AMP-activated protein kinase activation modulates progesterone secretion in granulosa cells from hen preovulatory follicles,” Journal of Endocrinology, vol. 190, no. 1, pp. 85–97, 2006. View at Publisher · View at Google Scholar · View at PubMed
66. B. Viollet, F. Andreelli, and S. B. Jørgensen, et al., “The AMP-activated protein kinase $\alpha 2$ catalytic subunit controls whole-body insulin sensitivity,” Journal of Clinical Investigation, vol. 111, no. 1, pp. 91–98, 2003. View at Publisher · View at Google Scholar
67. K. Ma, A. Cabrero, and P. K. Saha, et al., “Increased $\beta$-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin,” Journal of Biological Chemistry, vol. 277, no. 38, pp. 34658–34661, 2002. View at Publisher · View at Google Scholar · View at PubMed
68. P. Froment, F. Gizard, D. Defever, B. Staels, J. Dupont, and P. Monget, “Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition,” Journal of Endocrinology, vol. 189, no. 2, pp. 199–209, 2006. View at Publisher · View at Google Scholar · View at PubMed
69. Y.-M. Mu, T. Yanase, and Y. Nishi, et al., “Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells,” Biochemical and Biophysical Research Communications, vol. 271, no. 3, pp. 710–713, 2000. View at Publisher · View at Google Scholar · View at PubMed
70. K. Toda, T. Okada, C. Miyaura, and T. Saibara, “Fenofibrate, a ligand for $\text{PPAR}\alpha$ , inhibits aromatase cytochrome P450 expression in the ovary of mouse,” Journal of Lipid Research, vol. 44, no. 2, pp. 265–270, 2003. View at Publisher · View at Google Scholar · View at PubMed
71. T. N. Lovekamp and B. J. Davis, “Mono-(2-ethylhexyl) phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells,” Toxicology and Applied Pharmacology, vol. 172, no. 3, pp. 217–224, 2001. View at Publisher · View at Google Scholar · View at PubMed
72. R. Mansfield, R. Galea, M. Brincat, D. Hole, and H. Mason, “Metformin has direct effects on human ovarian steroidogenesis,” Fertility and Sterility, vol. 79, no. 4, pp. 956–962, 2003. View at Publisher · View at Google Scholar
73. A. La Marca, T. O. Egbe, G. Morgante, T. Paglia, A. Ciani, and V. De Leo, “Metformin treatment reduces ovarian cytochrome P-450c17$\alpha$ response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome,” Human Reproduction, vol. 15, no. 1, pp. 21–23, 2000. View at Publisher · View at Google Scholar
74. Y.-H. Liu, E.-M. Tsai, and Y.-L. Chen, et al., “Serum adiponectin levels increase after human chorionic gonadotropin treatment during in vitro fertilization,” Gynecologic and Obstetric Investigation, vol. 62, no. 2, pp. 61–65, 2006. View at Publisher · View at Google Scholar · View at PubMed
75. B. Löhrke, T. Viergutz, and S. K. Shahi, et al., “Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor $\gamma$ in lutein cells,” Journal of Endocrinology, vol. 159, no. 3, pp. 429–439, 1998. View at Publisher · View at Google Scholar
76. M. Mohan, S. Ryder, P. L. Claypool, R. D. Geisert, and J. R. Malayer, “Analysis of gene expression in the bovine blastocyst produced in vitro using suppression-subtractive hybridization,” Biology of Reproduction, vol. 67, no. 2, pp. 447–453, 2002. View at Publisher · View at Google Scholar
77. J. R. Wood, D. A. Dumesic, D. H. Abbott, and J. F. Strauss III, “Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 2, pp. 705–713, 2007. View at Publisher · View at Google Scholar · View at PubMed
78. M. Mitchell, D. T. Armstrong, R. L. Robker, and R. J. Norman, “Adipokines: implications for female fertility and obesity,” Reproduction, vol. 130, no. 5, pp. 583–597, 2005. View at Publisher · View at Google Scholar · View at PubMed
79. T. Sir-Petermann, B. Echiburú, and M. M. Maliqueo, et al., “Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome,” Human Reproduction, vol. 22, no. 7, pp. 1830–1836, 2007. View at Publisher · View at Google Scholar · View at PubMed
80. G. Pincus and E. V. Enzmann, “The comparative behavior of mammalian eggs in vivo and in vitro,” The Journal of Experimental Medicine, vol. 62, pp. 665–675, 1935. View at Publisher · View at Google Scholar
81. R. G. Edwards, “Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and human ovarian oocytes,” Nature, vol. 208, no. 8, pp. 349–351, 1965. View at Publisher · View at Google Scholar
82. J. Chen, E. Hudson, and M. M. Chi, et al., “AMPK regulation of mouse oocyte meiotic resumption in vitro,” Developmental Biology, vol. 291, no. 2, pp. 227–238, 2006. View at Publisher · View at Google Scholar · View at PubMed
83. C. LaRosa and S. M. Downs, “Stress stimulates AMP-activated protein kinase and meiotic resumption in mouse oocytes,” Biology of Reproduction, vol. 74, no. 3, pp. 585–592, 2006. View at Publisher · View at Google Scholar · View at PubMed
84. S. Bilodeau-Goeseels, M. Sasseville, C. Guillemette, and F. J. Richard, “Effects of adenosine monophosphate-activated kinase activators on bovine oocyte nuclear maturation in vitro,” Molecular Reproduction and Development, vol. 74, no. 8, pp. 1021–1034, 2007. View at Publisher · View at Google Scholar · View at PubMed
85. L. Tosca, S. Uzbekova, C. Chabrolle, and J. Dupont, “Possible role of AMPK in the metformin-mediated arrest of bovine oocytes at the GV stage during in vitro maturation,” to appear in Biology of Reproduction.
86. L. A. Stadtmauer, S. K. Toma, R. M. Riehl, and L. M. Talbert, “Impact of metformin therapy on ovarian stimulation and outcome in ‘coasted’ patients with polycystic ovary syndrome undergoing in-vitro fertilization,” Reproductive Biomedicine Online, vol. 5, no. 2, pp. 112–116, 2002.
87. R. S. Legro, H. X. Barnhart, and W. D. Schlaff, et al., “Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome,” New England Journal of Medicine, vol. 356, no. 6, pp. 551–566, 2007. View at Publisher · View at Google Scholar · View at PubMed